A process for obtaining biologically active compositions from emu oil is provided, wherein the compositions are obtained by molecular distillation of the oil, both the distillate and the distillation residue being biologically active compositions. More specifically, a process for obtaining biologically active compositions from refined emu oil is disclosed, which has the following steps: (a) feeding emu oil at a flow of between 1 to 300 kg/h*m2 to a molecular distillation column at a pressure between 0.0001 mbar and 0.05 mbar and at an evaporator temperature between 160° C. and 250° C., for generating a distillate and a residue; and (b) collecting the distillate from the column, the distillate being a biologically active composition, and (c) collecting the residue from the column, the residue being a biologically active composition.

The present invention provides a formulation capable of treating cramp and/or spasm in a subject, or reducing frequency of cramp and/or spasm in a subject, wherein the formulation comprises a dipeptide composition containing one or more imidazole-containing dipeptides, a turmeric product containing curcumin, and ancient peat minerals.

Disclosed herein is a topical formulation for treating psoriasis. The formulation comprises ground wheat and a wheat extract, ground barley and a barley extract, an oil and egg or a fraction thereof. Also disclosed is a method for treating psoriasis comprising applying the topical formulation to an affected area of a patient.

Disclosed is a method for improving eye conditions comprising orally administering to humans, an ethanol-soluble component-containing degradation product obtained by degrading a comb with a protease and removing a solid.

Disclosed is a method for improving eye conditions comprising orally administering to humans, an ethanol-soluble component-containing degradation product obtained by degrading a comb with a protease and removing a solid.

A nutraceutical dietary supplement formulation for the treatment of joint pain and discomfort may include astaxanthin powder; boswellia serrate gum resin extract; hyaluronic acid; undenatured type II (UC-II) collagen; eggshell membrane collagen powder; turmeric root extract; white willow bark extract; cayenne pepper extract; and Cat's Claw bark powder. The formulation may be formed into capsules for delivery to a user, wherein a therapeutically effective dosage of the formulation may be included in each capsule.

A nutraceutical dietary supplement formulation for the treatment of joint pain and discomfort may include astaxanthin powder; boswellia serrate gum resin extract; hyaluronic acid; undenatured type II (UC-II) collagen; eggshell membrane collagen powder; turmeric root extract; white willow bark extract; cayenne pepper extract; and Cat's Claw bark powder. The formulation may be formed into capsules for delivery to a user, wherein a therapeutically effective dosage of the formulation may be included in each capsule.

Methods and egg yolk powder containing compositions for improving skeletal muscle protein fractional synthetic rate (FSR) in mammals and inhibiting or reversing sarcopenia are provided.

Methods and egg yolk powder containing compositions for improving skeletal muscle protein fractional synthetic rate (FSR) in mammals and inhibiting or reversing sarcopenia are provided.

A composition having hair growth and/hair restoration effect that includes plasmalogen extracted from tissues of animal such as shellfish, sea squirt, and birds, and that can be used as external preparation or oral preparation.